+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States, July-November 2002



Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States, July-November 2002



Morbidity and Mortality Weekly Report 51(49): 1109-1112



In September 2002, the North Carolina Division of Public Health was notified of 2 cases of meningitis caused by Exophiala dermatitidis (Wangiella dermatitidis) who had received epidural injections of methylprednisolone acetate at outpatient pain management clinics.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 003763433

Download citation: RISBibTeXText


Related references

Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002. Mmwr. Morbidity and Mortality Weekly Report 51(49): 1109-1112, 2003

From the Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002. JAMA 289(3): 291-293, 2003

Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy. Clinical Infectious Diseases 47(11): 1372-1379, 2008

Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy - United States, 2012. Mmwr. Morbidity and Mortality Weekly Report 61(41): 839-842, 2012

West Nile virus activity--United States, November 14-20, 2002, and Missouri, January 1-November 9, 2002. Mmwr. Morbidity and Mortality Weekly Report 51(46): 1049-1051, 2002

Multi-institutional outbreak of Burkholderia cepacia complex associated with contaminated mannitol solution prepared in compounding pharmacy. American Journal of Infection Control 41(11): 1038-1042, 2014

Life-threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state. Pediatrics 118(1): E212-E215, 2006

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests. International Journal of Pharmaceutical Compounding 14(2): 142-149, 2010

Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies. State Legislatures 39(6): 22-23, 2013

Ensuring that injectable bicarbonate-buffered lidocaine-epinephrine complies with 2015 United States Pharmacopeia (USP) compounding provisions. Journal of the American Academy of Dermatology 75(2): 454-455, 2016

Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2. International Journal of Pharmaceutical Compounding 11(4): 313-323, 2007

A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. Clinical Infectious Diseases 45(5): 527-533, 2007

Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis. Biomed Research International 2017: 7915340-7915340, 2017

Quality-control analytical methods: aqua pura: water purification systems and United States pharmacopeia waters for the compounding pharmacy, part 1. International Journal of Pharmaceutical Compounding 15(2): 133-144, 2011